Vascular surgeon Andrew Olinde, MD, was named Chief Medical Officer at Baton Rouge General in December. In this role, Dr. Olinde is responsible for building positive relationships with the physician community and representing the General publicly on medical topics. In addition, he continues to see patients at the Vascular Specialty Center located on the General’s Bluebonnet campus. Read the Complete Article >>>
Read More
Archives for Steve Mitchell
Dr. Olinde on WAFB explains DVT and Varicose Veins
WAFB 9 News Baton Rouge, Louisiana News, Weather, Sports
Read More
Introducing the Zenith Fenestrated Graft
We’re thrilled to introduce you to the latest FDA-approved treatment technology for abdominal aortic aneurysms (AAA): the Zenith Fenestrated Graft. If you’re unaware of this condition, an AAA occurs when the walls of the abdominal portion of the aorta (the main blood vessel that delivers blood to your body) weaken and begin to bulge. Our new graft allows us to line the inner walls of the aorta to give the blood a new, reinforced path that doesn’t put pressure on the aneurysm and significantly reduces the risk of a rupture. The main benefit of the Zenith Fenestrated Graft is its
Read More
Dr. Joseph Griffin was featured on Channel 9 – WAFB’s morning show.
Baton Rouge Vascular Specialty Center’s Dr. Joseph Griffin was featured on WAFB’s morning show to discuss heart healthy lifestyle tips as well as the warning signs of vascular and cardiac issues.
Read More
FREE Vascular Screenings in January, February and March
Find out if you’re at risk for heart or vascular disease! Today, Vascular Specialty Center’s Dr. Andrew J. Olinde appeared on WBRZ-TV to discuss Baton Rouge General’s upcoming vascular screening events. Consisting of noninvasive ultrasound evaluation of the carotid artery, the screening involves looking for the formation of plaque, which correlates to plaque buildup in the coronary arteries, which is heart disease. Screening, which is completely free, will help Dr. Olinde and his team identify risk factors for heart disease. Screening events take place at Baton Rouge General’s Bluebonnet campus on January 22, 2015 February 26, 2015 March 26, 2015
Read More
Vascular Specialty Center Physician to Report Experience with Minimally-Invasive Laparoscopic Aortic Reconstruction
Dr. Andrew J. Olinde will discuss Vascular Specialty Center results of laparoscopic aortic repair at the 31st annual Northwestern Vascular Symposium on December 14th, 2006 in Chicago, IL. This meeting represents a major international forum for the specialty of vascular surgery and endovascular therapy. In conjunction with addressing the attendants, Vascular Specialty Center physicians will contribute a chapter for the accompanying textbook for the meeting – Trends in Vascular Surgery. Vascular Specialty Center is the leading center for laparoscopic aortic surgery in the United States having performed over 50 cases. “We are honored to have been invited to present our
Read More
Vascular Specialty Center and Neuromedical Center Collaborate For Stroke-Prevention Clinical Trial
Baton Rouge, LA – Vascular Specialty Center is pleased to announce their collaboration with the Neuromedical Center for enrollment into the CREST trial for stroke prevention. The only carotid stenting stroke prevention trial sponsored by the National Institutes of Health, Vascular Specialty Center ranks as a leading enrolling site for this landmark, multicenter clinical trial. “We wish to sincerely thank the neurologists and staff of the fine Neuromedical Center for joining with us in delivering the latest vascular technologies to the people of South Louisiana”, says Dr. Andrew Olinde, Vascular Specialty Center physician.
Read More
Vascular Specialty Center Selected to Assess Effectiveness of New Vascular Graft
Baton Rouge, LA – Vascular Specialty Center physicians in conjunction with Vascular Specialty Center Clinical Research division has been selected as one of a few national sites to assess the efficacy of a new vascular graft. The GORE PROPATEN Vascular Graft is the first ePTFE vascular graft that reduces clotting and is designed to address the clinical problem of thrombotic vascular graft failure. The GORE PROPATEN Vascular Graft is the first and only ePTFE-heparin combination in an emerging class of medical products that combine mechanical and biological elements. It is designed to address the gap in clinical performance between synthetic
Read More
Vascular Specialty Center Physician Co-authors Results of Leading Vascular Clinical Trial Results Zymo trial
Baton Rouge, LA – A Vascular Specialty Center physician has recently co-authored results of a Phase 3 multiple site, randomized, double-blind, controlled trial designed to evaluate the comparative efficacy and safety of rhThrombin and bovine thrombin in patients undergoing spinal surgery, hepatic resection, peripheral arterial bypass surgery, or arteriovenous graft formation for hemodialysis access (Journal of the American College of Surgeons 2007 Aug; 205(2):256-65.). Results of this trial suggest that rhThrombin has comparable efficacy, a similar safety profile, and is considerably less immunogenic than bovine thrombin when used for surgical hemostasis. “As a principle investigator and leading enroller for the
Read More
Vascular Specialty Center physician first in region to use novel device for treatment of peripheral vascular disease
Baton Rouge LA – Vascular Specialty Center (VSC) physician Dr. Joseph M. Griffin recently became the first physician in the greater Baton Rouge/Gulf South region to use the Bard Crosser Catheter in the treatment of vascular disease. Dr. Griffin used the FDA approved Bard Crosser Catheter to restore blood flow in a long segment of blocked artery in order to prevent amputation. “This new technology is increasing our success rates of crossing arterial occlusions as compared to prior technology. In some circumstances of arterial occlusions the only option is to perform conventional bypass surgery; but now we are able treat
Read More